Avego Management logo

Avego Management

North America, Georgia, United States, Alpharetta

Description

Avego Management provides investment consultation for companies and capital investment assistance within the healthcare industry.

Investor Profile

Avego Management has made 2 investments, with 1 in the past 12 months and 50% as lead.

Stage Focus

  • Series C (50%)
  • Series Unknown (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Health Care
  • Life Science
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Avego Management frequently co-invest with?

Abingworth
Europe, England, United Kingdom, London
Co-Investments: 1
Altitude Life Science Ventures
North America, Colorado, United States, Durango
Co-Investments: 1
5AM Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 1
Co-Investments: 1
CH
North America, New York, United States, New York
Co-Investments: 1
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 1
PFM Health Sciences
North America, California, United States, San Francisco
Co-Investments: 1
Redmile Group
North America, California, United States, San Francisco
Co-Investments: 1
Sanofi Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 1

What are some of recent deals done by Avego Management?

PBS Biotech

Camarillo, California, United States

PBS Biotech is a manufacturer of single-use bioreactor systems and a provider of process development services for the cell therapy industry.

BiotechnologyHealth CareLife ScienceMedical Device
Series UnknownJan 6, 2025
Amount Raised: $17,000,000
Escient Pharmaceuticals

San Diego, California, United States

Escient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series CNov 28, 2022
Amount Raised: $120,000,000